Agilent opens Asia Glycomics Education Center
Agilent Technologies (California, USA) has opened the Asia Glycomics Education Center in South Korea, building on the recent collaboration with Chungham National University (Daejon, South Korea) through the university's Graduate School of Analytical Science and Technology (GRAST).
Agilent Technologies (California, USA) has opened the Asia Glycomics Education Center in SouthKorea, building on the recent collaboration with Chungham National University (Daejon, SouthKorea) through the university’s Graduate School of Analytical Science and Technology (GRAST).
The center will provide education and training for industry and academics free of chargethroughout the Asia-Pacific area. The university will design and develop training programmes forglycan analysis — the study of complex sugars — used in the development of biomarkers andtherapeutic antibodies. Agilent will provide new analytical technology for the center.
“Since we first started collaborating with Agilent in 2011, our university has enjoyed access tothe latest analytical and scientific technologies for research in glycomics. Our highly talented teamat GRAST, led by professor Hyun-Joo An, has made a number of significant findings, which havebeen shared with the global scientific community through papers and speaking engagements,”said university president Sang-Chul Jung. He added, “This lives up to our university’s motto —‘Creativity, development, and service to the community’ — and we are pleased to further thiscollaboration with Agilent.”
For more information please visit:
www.agilent.com
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
